Fluorescence Imaging in Finding Tumors in Patients With Kidney Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

October 20, 2011

Primary Completion Date

October 9, 2017

Study Completion Date

October 9, 2017

Conditions
Recurrent Renal Cell CancerStage I Renal Cell CancerStage II Renal Cell Cancer
Interventions
PROCEDURE

fluorescence imaging

Undergo NIR fluorescence imaging with ICG on the da Vinci surgical system

PROCEDURE

laparoscopic surgery

Undergo standard approach robot-assisted laparoscopic partial nephrectomy

DRUG

indocyanine green

Given IV

Trial Locations (1)

91010

City of Hope Medical Center, Duarte

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT01281488 - Fluorescence Imaging in Finding Tumors in Patients With Kidney Tumors | Biotech Hunter | Biotech Hunter